31P Survival outcomes in BRCA pathogenetic mutated, variant of unknown significance, and wild type ovarian cancer patients treated with PARP inhibitors
Titel:
31P Survival outcomes in BRCA pathogenetic mutated, variant of unknown significance, and wild type ovarian cancer patients treated with PARP inhibitors
Auteur:
Musacchio, L. Marchetti, C. Boccia, S.M. Cassani, C. Ventriglia, J. Salutari, V. Camarda, F. Ghizzoni, V. Giudice, E. Carbone, M.V. Pignata, S. Scambia, G. Lorusso, D.